@FluGenInc profile picture
FluGen, Inc. @FluGenInc

Transforming vaccine efficacy in respiratory disease

Joined August 2012
  • Tweets 224
  • Following 111
  • Followers 291
2 Photos and videos
FluGen's M2SR in Lancet ID today showing superior resposne when combined with Fluzone High Dose in older adults versus Fluzone High Dose alone (thelancet.com/journals/lanin…) This could be a big improvement in preventing flu... bit.ly/3S3gvMC
1
92
And while you're at it- take a look at Healthcare Business Today to read more about M2SR's potential healthcarebusinesstoday.com/…

M2sr Vaccine Technology: How Flugen Is Introducing New Solutions And Strategies For Influenza And...

A major limitation of currently available influenza vaccines is their modest efficacy, which stems from several problems: their limited ability to block

healthcarebusinesstoday.com
1
121
Check us out in Drug Discovery & Development! drugdiscoverytrends.com/dual…
79
On the latest episode of the @BioBossPodcast, FluGen Founder and CEO Paul Radspinner discusses his career journey and the science behind FluGen’s vaccine program. To hear the full podcast, head to the BioBoss website: bioboss.buzzsprout.com/

BioBoss

BioBoss is a podcast about leadership in the biopharma community. Hear directly from the founders and CEOs of today's most innovative companies. Listen in as Wyant Simboli Principal and branding...

bioboss.buzzsprout.com
1
We're excited to announce completion of first cohort in age de-escalation clinical trial of M2SR flu vaccine candidate in pediatric subjects ages 6 Months to 17 Years! flugen.com/news/

1
1
More confirmation that mucosal immunity is critical cnn.com/2022/07/18/health/mu…

With a sniff or a swallow, new vaccines aim to put the brakes on Covid-19 spread | CNN

Injected vaccines against the coronavirus that causes Covid-19 have been hugely successful, saving nearly 20 million lives globally in their first year of use and slashing the pandemic’s death toll...

cnn.com
FluGen, Inc. retweeted
WARF (Wisconsin Alumni Research Foundation)@WARF_News
11 Aug 2022
.@UWMadison investigators are eligible to apply for @DeptofDefense funding to catalyze innovative medical solutions for military applications and rapidly migrate those technologies out of the lab and into use. #WisconsinInnovates engineering.wisc.edu/blog/wi…

With $10B in potential funding, UW-Madison among group driving military healthcare solutions -...

As key members of a consortium of university and industry partners, University of Wisconsin-Madison investigators can compete for funding—from an overall pot of $10 billion—to catalyze innovative...

engineering.wisc.edu
1
2
FluGen, Inc. retweeted
University Research Park@UWMadisonURP
28 Jun 2022
.@FluGenInc announced the dosing of its first subject, in an unprecedented study of older adults ages 65-85 years, to evaluate the effectiveness of its intranasal #flu #vaccine. ow.ly/hN7g50JJa8c #clinicaltrials
1
2
We are pleased to announce the first subject has been dosed in phase 1b clinical trial of our intranasal M2SR Flu Vaccine, co-administered with High Dose Vaccine, in older adults! See flugen.com/news/ for full announcement
1
FluGen, Inc. retweeted
Andrew Lloyd ALA@ALA_Group
21 Jun 2022
[ALA Client News] #Naobios delivers @flugeninc’s M2SR #influenza #vaccine candidate for upcoming clinical trials @FluSpinner ala.com/projects/naobios-del…
1
FluGen to Present at 40th Annual J.P. Morgan Healthcare Conference 1/12/22 @ 4:30 PM E.T. Visit flugen.com/for-investors/ for more info!
1
1
FluGen management will be presenting at Baird's 2021 Global Healthcare Conference tonight @ 5:30 PM ET watch it here: kvgo.com/baird-2021-global-h…
Journal of Infectious Diseases publishes positive data from our Ph.2 human challenge study of our M2SR #flu #vaccine candidate, showing protection against highly drifted strain of H3N2 flu [prn.to/3xeng0J]

FluGen Announces Publication of Positive Results from Phase 2 Human Challenge Study of Its M2SR...

/PRNewswire/ -- FluGen, Inc., a clinical-stage vaccine company transforming vaccine efficacy in infectious respiratory diseases, today announced the...

prnewswire.com
2
3
We are happy to announce that @DeptofDefense has awarded us funding to conduct a safety & immunogenicity study to asses our M2SR #flu #vaccine candidate and the current standard of care high dose vaccine in adults 65 and older prn.to/2UbMcs2

1
1
5
Watch FluGen President & CEO Paul Radspinner speak at the @Jefferies 2021 Virtual Healthcare Conference wsw.com/webcast/jeff174/flu/…
We are pleased to launch the first #flu #vaccine study of M2SR in adults up to 85. Funded by @NIH, our study will assess safety, tolerability, and immunological response in people vulnerable to flu. prn.to/2TcY3Wd
2
3
FluGen, Inc. retweeted
Aaron@aaronolver
17 Dec 2020
How @UWMadisonURP started How it's going
1
6
25
FluGen, Inc. retweeted
Katherine Davis@katmdavis
30 Sep 2020
ICYMI, watch my interview with @FluGenInc CEO Paul Radspinner. We chatted about FluGen’s approach to developing a Covid-19 vaccine, what the biggest challenges are, and what vaccine-makers need to do to ensure patients they are safe and effective. bizjournals.com/milwaukee/in…

FluGen CEO talks Covid-19 vaccine development in Bytes with the Beat event

At Wisconsin Inno’s latest virtual event, Paul Radspinner, the president and CEO of FluGen, revealed the startup’s progress on developing a Covid-19 vaccine.

bizjournals.com
2
4
Reminder: you can still register for tomorrow's virtual fireside chat to hear from our CEO Paul Radspinner
Katherine Davis@katmdavis
22 Sep 2020
Mark your calendars! I'll be hosting a fireside chat with @FluGenInc CEO Paul Radpsinner on Sept. 29 to discuss the company's progress on developing a Covid-19 vaccine. FluGen was named one of @WisconsinInno's #CrisisInnovators last month. Register here: register.gotowebinar.com/reg…
2
1
In this episode of #ExecutiveCorner, we'll be taking a closer look with Andy Skibo from @FluGenInc & @RfwrightLSL from Life Science Leader at what factors are important for #risk mitigation and #leadership in the #biomanufacturing industry. Listen now ➡️ biomanamerica.com/podcast/
0:30
3
1
Load more